These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 10921108)
21. [Study on serum soluble interleukin-6 receptor levels in patients with malignant hematological diseases]. Li D; Yang J; Cui W; Ma C; Ma C; Ji E; Li J; Li G; Ma C Zhonghua Xue Ye Xue Za Zhi; 1997 Nov; 18(11):577-80. PubMed ID: 15625895 [TBL] [Abstract][Full Text] [Related]
22. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus. Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976 [TBL] [Abstract][Full Text] [Related]
23. [Diagnostic and prognostic significance of serum soluble interleukin 2 receptor in children with malignancies]. Bień E; Balcerska A; Ciesielski D Wiad Lek; 2006; 59(1-2):10-5. PubMed ID: 16646285 [TBL] [Abstract][Full Text] [Related]
24. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo. Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356 [TBL] [Abstract][Full Text] [Related]
26. Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia. Chrobák L; Podzimek K; Plísková L; Kerekes Z; Zák P; Voglová J; Spacek J; Palicka V Neoplasma; 1996; 43(5):321-5. PubMed ID: 8996552 [TBL] [Abstract][Full Text] [Related]
27. Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma. Chang CS; Liu HW; Lin SF; Chen TP Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):132-7. PubMed ID: 2605973 [TBL] [Abstract][Full Text] [Related]
28. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery]. Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193 [TBL] [Abstract][Full Text] [Related]
29. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma]. Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970 [TBL] [Abstract][Full Text] [Related]
30. The serum levels of soluble interleukin-2 receptor levels in patients with obstructive jaundice. Yüceyar H; Kokuludag A; Coker A; Ersöz G; Keskinoglu A; Güler A; Cavusoglu H Hepatogastroenterology; 1996; 43(10):949-53. PubMed ID: 8884319 [TBL] [Abstract][Full Text] [Related]
31. Serum soluble interleukin 2 receptor alpha and soluble CD8 levels in patients with gynecological malignancies undergoing radiotherapy. Frydecka I; Rusiecka M; Kuliczkowski K; Kornafel J Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):123-6. PubMed ID: 8915516 [TBL] [Abstract][Full Text] [Related]
33. [Diagnostic value of serum soluble interleukin-2 receptor levels in interstitial pneumonia of the patients with hematological disorders]. Kohda K; Koike K; Matsumoto S; Kida M; Nakazawa O; Nagamachi Y; Mizushima S Rinsho Ketsueki; 1997 Feb; 38(2):146-8. PubMed ID: 9059070 [TBL] [Abstract][Full Text] [Related]
34. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy. Dejica D Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973 [TBL] [Abstract][Full Text] [Related]
35. Serum evaluation of the balance between soluble interleukin-2 and interleukin-4 receptors. Fujita N; Okamoto Y; Gotoh Y; Yada Y; Suzuki Y; Ando T; Togari H; Nishida M Cytokine; 2005 Nov; 32(3-4):143-8. PubMed ID: 16226465 [TBL] [Abstract][Full Text] [Related]
36. [Serum soluble IL-2 receptor level in patients with sarcoidosis]. Ina Y; Takada K; Noda M; Satou T; Hashiba H; Miyachi A; Ito S; Iijima N; Yamamoto M Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A; Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608 [TBL] [Abstract][Full Text] [Related]
39. Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms. Lissoni P; Barni S; Tancini G; Viviani S; Rovelli F; Rescaldani R; Fiorelli G J Biol Regul Homeost Agents; 1989; 3(3):131-3. PubMed ID: 2560317 [TBL] [Abstract][Full Text] [Related]